青少年Fontan患者心外管道狭窄与肝纤维化加重相关
该回顾性研究纳入93例青少年Fontan患者,分析心外管道狭窄与Fontan血流动力学、运动能力、实验室检查及肝纤维化的关联。结果显示管道直径缩小与肝纤维化加重、蛋白丢失性肠病及运动耐力下降相关,管道直径每增加1 mm,肝纤维化加重风险降低54.3%。
要点
- 心外管道狭窄与青少年Fontan患者肝纤维化加重独立相关
- 管道最小直径与峰值耗氧量及无氧阈耗氧量正相关
- 蛋白丢失性肠病患者管道直径更小,运动能力更差
核心结论
- 心外管道狭窄与青少年Fontan患者肝纤维化加重、蛋白丢失性肠病及运动耐力下降相关。
- 管道最小直径每增加1 mm,肝纤维化加重风险降低54.3%(OR 0.457,95%CI 0.264-0.791,P=.005)。
研究设计与样本
- 回顾性分析93例2018至2022年间接受空腹心肝磁共振成像的Fontan患者。
- 测量心外管道最小直径和横截面积,采用延迟钆增强序列对肝纤维化分级。
- 使用Spearman相关、Mann-Whitney检验及多变量回归分析管道大小与肝纤维化的关系。
主要发现
- Fontan术后中位10.2年(IQR 8.1-12.7),管道直径较原始尺寸中位缩小27.3%(IQR 22.7%-31.8%)。
- 管道最小直径与峰值耗氧量相关(ρ=.324,P=.004),与无氧阈峰值耗氧量相关(ρ=.372,P=.002)。
- 蛋白丢失性肠病患者管道直径更小(14.0[13.0-15.5] mm vs 16.0[14.0-17.0] mm,P=.020)。
- 肝纤维化超过轻度者管道直径更小(14.0[13.8-15.3] mm vs 16.0[15.0-17.0] mm,P<.001)。
临床怎么用
- 对青少年Fontan患者应关注心外管道狭窄,必要时评估管道扩张策略以减轻肝脏淤血。
- 管道狭窄可能提示蛋白丢失性肠病和运动能力下降风险,需综合评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study objective was to investigate the association between extracardiac conduit restriction, as assessed by magnetic resonance imaging, Fontan hemodynamics, exercise capacity, laboratory tests, and liver fibrosis in adolescent Fontan patients. METHODS: We retrospectively analyzed 93 Fontan patients who underwent fasting heart-liver magnetic resonance imaging between 2018 and 2022. Extracardiac conduit minimal diameter and cross-sectional area were measured, and liver fibrosis was graded on delayed gadolinium enhancement sequences. Correlations between magnetic resonance imaging and clinical/functional/laboratory data were explored using Spearman's correlation and Mann-Whitney test. Multivariable regression was performed to assess the effect of extracardiac conduit size on liver fibrosis development. RESULTS: After a median of 10.2 (interquartile range, 8.1-12.7) years post-Fontan, extracardiac conduit diameter had a median reduction of 27.3% (22.7%-31.8%) from its original size. Minimal extracardiac conduit diameter correlated with peak oxygen consumption (ρ = .324, P = .004) and peak oxygen consumption at anaerobic threshold (ρ = .372, P = .002). Patients with protein-losing enteropathy exhibited smaller extracardiac conduit diameters (14.0 [13.0-15.5] mm vs 16.0 [14.0-17.0] mm; P = .020) compared with those without protein-losing enteropathy. Patients with more than mild liver fibrosis had smaller extracardiac conduit diameters (14.0 [13.8-15.3] mm vs 16.0 [15.0-17.0] mm, P < .001) compared with those with none-mild fibrosis. At multivariable regression analysis, 1-mm increase in extracardiac conduit minimal diameter decreased the risk of more than mild liver fibrosis by 54.3% (odds ratio, 0.457, 95% CI, 0.264-0.791, P = .005). CONCLUSIONS: Extracardiac conduit restriction is associated with increased liver fibrosis, protein-losing enteropathy, and reduced exercise tolerance in adolescent Fontan patients. These findings suggest that conduit upsizing strategies may be considered to alleviate hepatic congestion and improve functional capacity.
引用
- Ponzoni M, Saleh J, Chaturvedi RR, et al. Extracardiac conduit restriction is associated with increased liver fibrosis in adolescent Fontan patients. J Thorac Cardiovasc Surg. 2025. PMID: 41047073. doi:10.1016/j.jtcvs.2025.09.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。